News for Chinook Therapeutics, Inc. (KDNY)

**media[556085]**

**media[546129]**

**media[521476,521477]**

**media[516006]**

EMERYVILLE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. ( MGX), a precision genetic medicines company committed to developing curative therapeu

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement...

Kidney disease treatment company looks to build on work of Chinook Therapeutics, acquired by Novartis last year.

/PRNewswire-PRWeb/ -- The Lustgarten Foundation, the largest private funder of pancreatic cancer research in the world, today announced the appointment of two...

2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner

Vertex Pharmaceuticals (VRTX) to acquire Alpine Immune Sciences (ALPN) for $4.9b in cash. Check out why I think this deal may be a little overpriced.

Alpine Immune Sciences has discarded two drug candidates since joining the Nasdaq in 2027. Read why ALPN stock price has risen 200% in six months owing to its latest lead candidate.

Visiongain has published a new report entitled Antisense Oligonucleotide (ASO) Therapeutics Market Report 2023-2033: Forecasts by Therapeutic Application...

NEW YORK, July 25, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...

NEW YORK, July 19, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York...

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

NEW YORK, June 13, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning... | June 13, 2023

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.56%

Travere Therapeutics and Vera Therapeutics are also developing treatments for rare kidney disease

U.S. stocks traded higher toward the end of trading, with Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.19% to 33,939.74 while the NASDAQ rose 1% to 13,391.54. The S&P 500, also rose, gaining, 0.47% to 4,319.22.